Public limited company · Niel · incorporated on 06/01/2011 · 4,3 ETP
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 354,8 k € | +59.5% | 222,5 k € | +53.8% | 144,7 k € | -52.1% | 302,2 k € | — | — | — | — | — | — | — | 241,2 k € | +77.9% | 135,6 k € | |||||||||
| Gross margin | -40,9 k € | +80.8% | -213,1 k € | +51.2% | -437,2 k € | -185.8% | -153,0 k € | -1248.5% | 13,3 k € | +103.3% | -406,0 k € | +26.9% | -555,5 k € | -2488.6% | 23,3 k € | -72.6% | 85,0 k € | +194.5% | 28,9 k € | +7.0% | 27,0 k € | -46.8% | 50,7 k € | -26.4% | 68,9 k € | |
| EBITDA | -377,2 k € | -1.1% | -373,3 k € | +41.1% | -633,3 k € | -81.9% | -348,3 k € | -56.3% | -222,8 k € | +73.8% | -850,7 k € | -7.7% | -790,0 k € | -1524.0% | -48,6 k € | -481.1% | -8,4 k € | +64.6% | -23,6 k € | -15.2% | -20,5 k € | -252.1% | 13,5 k € | -80.4% | 68,8 k € | |
| Operating profit | -566,0 k € | +0.3% | -567,8 k € | +31.0% | -823,3 k € | -60.1% | -514,2 k € | -56.8% | -328,0 k € | +64.5% | -923,1 k € | -14.6% | -805,7 k € | -1319.7% | -56,8 k € | -251.7% | -16,1 k € | +46.7% | -30,3 k € | -9.7% | -27,6 k € | -453.6% | 7,8 k € | -87.2% | 60,9 k € | |
| Profit/loss | -624,0 k € | -3.2% | -604,8 k € | +28.6% | -846,7 k € | -64.1% | -515,9 k € | -56.8% | -329,1 k € | +64.6% | -928,5 k € | -14.7% | -809,7 k € | -1242.7% | -60,3 k € | -169.6% | -22,4 k € | +24.1% | -29,5 k € | -15.4% | -25,5 k € | -508.6% | 6,2 k € | -88.1% | 52,6 k € | |
| Equity | -747,1 k € | -506.9% | -123,1 k € | -125.6% | 481,7 k € | -63.7% | 1,3 M € | -28.0% | 1,8 M € | +47.1% | 1,3 M € | -20.8% | 1,6 M € | +3689.4% | 41,7 k € | -59.1% | 102,1 k € | -18.0% | 124,4 k € | -19.1% | 153,9 k € | -14.2% | 179,4 k € | +146.9% | 72,7 k € | |
| Total assets | 1,4 M € | -13.2% | 1,6 M € | -11.2% | 1,8 M € | +0.6% | 1,8 M € | -25.2% | 2,4 M € | +61.7% | 1,5 M € | -16.7% | 1,8 M € | +1641.7% | 102,7 k € | -36.5% | 161,7 k € | +11.0% | 145,7 k € | -19.6% | 181,3 k € | -1.2% | 183,5 k € | +58.5% | 115,8 k € | |
| Cash | 75,9 k € | -40.8% | 128,1 k € | -64.6% | 361,6 k € | +9.4% | 330,5 k € | -72.1% | 1,2 M € | +33.8% | 886,6 k € | -41.8% | 1,5 M € | +21531.1% | 7,0 k € | -39.8% | 11,7 k € | -80.3% | 59,3 k € | -6.4% | 63,4 k € | -37.2% | 100,9 k € | -0.2% | 101,2 k € | |
| Debts | 1,7 M € | +35.0% | 1,2 M € | +27.1% | 966,6 k € | +1133.1% | 78,4 k € | -34.0% | 118,7 k € | -36.9% | 188,0 k € | +0.3% | 187,5 k € | +207.4% | 61,0 k € | +2.2% | 59,7 k € | +181.1% | 21,2 k € | -22.4% | 27,4 k € | +559.4% | 4,2 k € | -90.4% | 43,2 k € | |
| Staff | 4,3 | 3,3 | 3,3 | 2,4 | 3,2 | 5,7 | 3,1 | — | 1,8 | 1 | 1 | 1 | — | |||||||||||||
Company — Opening of bankruptcy.
Public limited company loss-making in the latest fiscal year. Cash position declining (-40.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
OXYPOINT is a Public limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Niel. It employs on average 4,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette